In vivo, subcutaneous infusion of CLR01 on a transgenic mouse model of Familial Amyloid Polyneuropathy (FAP) restored the TTR plasma level to healthy conditions, significantly reduced TTR extracellular accumulation in several organs and rescued tissue damage [62]. This evidence concerns the gene TTR and familial amyloid neuropathy.